- Home
- NVVE vs JAGX Comparison
NVVE vs JAGX Comparison
Compare NVVE & JAGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVVE
- JAGX
- Stock Information
- Founded
- NVVE 1996
- JAGX 2013
- Country
- NVVE United States
- JAGX United States
- Employees
- NVVE N/A
- JAGX N/A
- Industry
- NVVE Oil Refining/Marketing
- JAGX Biotechnology: Pharmaceutical Preparations
- Sector
- NVVE Energy
- JAGX Health Care
- Exchange
- NVVE Nasdaq
- JAGX Nasdaq
- Market Cap
- NVVE 4.2M
- JAGX 3.9M
- IPO Year
- NVVE N/A
- JAGX N/A
- Fundamental
- Price
- NVVE $0.26
- JAGX $1.96
- Analyst Decision
- NVVE
- JAGX Strong Buy
- Analyst Count
- NVVE 0
- JAGX 1
- Target Price
- NVVE N/A
- JAGX $60.00
- AVG Volume (30 Days)
- NVVE 5.1M
- JAGX 145.3K
- Earning Date
- NVVE 11-11-2025
- JAGX 11-12-2025
- Dividend Yield
- NVVE N/A
- JAGX N/A
- EPS Growth
- NVVE N/A
- JAGX N/A
- EPS
- NVVE N/A
- JAGX N/A
- Revenue
- NVVE $4,949,747.00
- JAGX $11,810,000.00
- Revenue This Year
- NVVE $892.33
- JAGX $22.41
- Revenue Next Year
- NVVE N/A
- JAGX $30.00
- P/E Ratio
- NVVE N/A
- JAGX N/A
- Revenue Growth
- NVVE N/A
- JAGX 15.96
- 52 Week Low
- NVVE $0.18
- JAGX $1.57
- 52 Week High
- NVVE $8.76
- JAGX $35.25
- Technical
- Relative Strength Index (RSI)
- NVVE 30.21
- JAGX 48.98
- Support Level
- NVVE $0.23
- JAGX $1.60
- Resistance Level
- NVVE $0.28
- JAGX $2.16
- Average True Range (ATR)
- NVVE 0.06
- JAGX 0.12
- MACD
- NVVE -0.00
- JAGX 0.06
- Stochastic Oscillator
- NVVE 25.14
- JAGX 66.10
About NVVE Nuvve Holding Corp.
Nuvve Holding Corp is accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) technology. It helps to support the integration of renewable energy sources, including solar and wind. Its Grid Integrated Vehicle (GIV) platform is refueling the next generation of electric vehicle fleets through bidirectional charging solutions. It has a geographic presence in the United States, the United Kingdom, and Denmark, of which it generates the majority of its revenue in the United States.
About JAGX Jaguar Health Inc.
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.